One patient prescribed Wegovy no longer needed medication for blood pressure or rheumatoid arthritis. Another patient on Zepbound saw arthritis improvement. Some practitioners note intriguing secondary effects beyond weight loss.
Doctors are observing the potential of GLP-1 agonist drugs Wegovy and Zepbound to address obesity-related issues like arthritis. Controversy exists on prioritizing obesity treatment over related conditions like high blood sugar.
#weight-loss-drugs #secondary-health-benefits #arthritis-treatment #glp-1-agonist-drugs #obesity-management
[
Collection
]
[
|
...
]